Duerst RJ, Morrison LA.
Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNaseL.
Virology. 2007 Apr 10;360(2):322-8.
Pubmed Abstract link: 17157346
Geiss BJ, Cano GL, Tavis JE, Morrison LA.
Herpes simplex virus 2 VP22 phosphorylation induced by cellular and viral
kinases does not influence intracellular localization.
Virology. 2004 Dec 5;330(1):74-81.
Pubmed Abstract link: 15527835
Morrison LA.
The Toll of herpes simplex virus infection.
Trends Microbiol. 2004 Aug;12(8):353-6. Review.
Pubmed Abstract link: 15276609
Stuart PM, Summers B, Morris JE, Morrison LA, Leib DA.
CD8(+) T cells control corneal disease following ocular infection with herpes
simplex virus type 1.
J Gen Virol. 2004 Jul;85(Pt 7):2055-63.
Duerst RJ, Morrison LA.
Herpes simplex virus 2 virion host shutoff protein interferes with type I
interferon production and responsiveness.
Virology. 2004 Apr 25;322(1):158-67.
Duerst RJ, Morrison LA.
Innate immunity to herpes simplex virus type 2.
Viral Immunol. 2003;16(4):475-90. Review.
Murphy JA, Duerst RJ, Smith TJ, Morrison LA.
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta
interferon but not adaptive immune responses during primary infection in vivo.
J Virol. 2003 Sep;77(17):9337-45.
Thebeau LG, Morrison LA.
Mechanism of reduced T-cell effector functions and class-switched antibody
responses to herpes simplex virus type 2 in the absence of B7 costimulation.
J Virol. 2003 Feb;77(4):2426-35.
Keadle TL, Laycock KA, Morris JL, Leib DA, Morrison LA, Pepose JS, Stuart
PM.
Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity
of recurrent herpetic stromal keratitis in mice.
J Gen Virol. 2002 Oct;83(Pt 10):2361-5.
Morrison LA.
Vaccines against genital herpes: progress and limitations.
Drugs. 2002;62(8):1119-29. Review.
Keadle TL, Morrison LA, Morris JL, Pepose JS, Stuart PM.
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent
herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
J Virol. 2002 Apr;76(8):3615-25.
Thebeau LG, Morrison LA.
B7 costimulation plays an important role in protection from herpes simplex
virus type 2-mediated pathology.
J Virol. 2002 Mar;76(5):2563-6.
Smith TJ, Morrison LA, Leib DA.
Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants.
J Virol. 2002 Mar;76(5):2054-61.
Geiss BJ, Tavis JE, Metzger LM, Leib DA, Morrison LA.
Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation.
J Virol. 2001 Nov;75(22):10721-9.
Da Costa XJ, Morrison LA, Knipe DM.
Comparison of different forms of herpes simplex replication-defective mutant
viruses as vaccines in a mouse model of HSV-2 genital infection.
Virology. 2001 Sep 30;288(2):256-63.
Prejean C, Sarma T, Kurnasov O, Usacheva A, Hemmings B, Cantley L, Fruman
DA, Morrison LA, Buller RM, Colamonici OR.
Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and
herpes simplex virus-induced cell death through the activation of distinct
downstream effectors.
J Immunol. 2001 Oct 15;167(8):4553-9.
Morrison LA, Zhu L, Thebeau LG.
Vaccine-induced serum immunoglobin contributes to protection from herpes simplex
virus type 2 genital infection in the presence of immune T cells.
J Virol. 2001 Feb;75(3):1195-204.
Geiss BJ, Smith TJ, Leib DA, Morrison LA.
Disruption of virion host shutoff activity improves the immunogenicity and
protective capacity of a replication-incompetent herpes simplex virus type
1 vaccine strain.
J Virol. 2000 Dec;74(23):11137-44.
Born TL, Morrison LA, Esteban DJ, VandenBos T, Thebeau LG, Chen N, Spriggs
MK, Sims JE, Buller RM.
A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell
response.
J Immunol. 2000 Mar 15;164(6):3246-54.
Kim ES, Li H, McCulloch PF, Morrison LA, Yoon KW, Xu XM.
Spatial and temporal patterns of transneuronal labeling in CNS neurons after
injection of pseudorabies virus into the sciatic nerve of adult rats.
Brain Res. 2000 Feb 28;857(1-2):41-55.
Morrison LA, Da Costa XJ, Knipe DM.
Influence of mucosal and parenteral immunization with a replication-defective
mutant of HSV-2 on immune responses and protection from genital challenge.
Virology. 1998 Mar 30;243(1):178-87.
Morrison LA, Knipe DM.
Contributions of antibody and T cell subsets to protection elicited by immunization
with a replication-defective mutant of herpes simplex virus type 1.
Virology. 1997 Dec 22;239(2):315-26.
Brubaker JO, Thompson CM, Morrison LA, Knipe DM, Siber GR, Finberg RW.
Th1-associated immune responses to beta-galactosidase expressed by a replication-defective
herpes simplex virus.
J Immunol. 1996 Aug 15;157(4):1598-604.
Morrison LA, Knipe DM.
Mechanisms of immunization with a replication-defective mutant of herpes simplex
virus 1.
Virology. 1996 Jun 15;220(2):402-13.
Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT.
Viral replication is required for induction of ocular immunopathology by herpes
simplex virus.
J Virol. 1996 Jan;70(1):101-7.